Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

Warrants (Tables)

6 Months Ended

Mar. 31, 2020

Warrants And Rights Note Disclosure [Abstract]

The following table summarizes information about the Company’s warrants at March 31, 2020 and September 30, 2019, respectively:

Number of units -

Series B Convertible

preferred warrants

Weighted Average

Exercise Price

Weighted Average

Remaining Contractual

Term (in years)

Intrinsic Value

Outstanding and Exercisable at September 30,

2019

118,029

20.80

0.53

—

Outstanding and Exercisable at March 31, 2020

118,029

20.80

1.85

—

Summary of Information Assuming Warrants are Exercised and Exchanged for Common Shares

The warrants may be exchanged for shares of common stock at a ratio of one share of Series B Preferred Stock into five common shares. The following table provides information assuming the warrants are exercised and exchanged for common shares:

Number of units -

Series B Convertible

preferred warrants

Weighted Average

Exercise Price

Weighted Average

Remaining Contractual

Term (in years)

Intrinsic Value

Outstanding and Exercisable at September 30,

2019

590,147

4.16

0.53

2,602

Outstanding and Exercisable at March 31, 2020

590,147

4.16

1.85

649

Summary of Warrants Outstanding and Exercisable

The exercise price for the Series B Convertible Preferred Stock warrants outstanding and exercisable at March 31, 2020 and September 30, 2019, are as follows:

Series B Convertible Preferred
Outstanding				Exercisable
Number of Warrants		Exercise Price		Number of Warrants		Exercise Price
	54,396	$	16.60		54,396	$	16.60
	17,857		16.80		17,857		16.80
	12,383		24.30		12,383		24.30
	33,393		28.50		33,393		28.50
	118,029				118,029